Institutional investors hold a majority ownership of PDLI through the 85.45% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2015, these large investors purchased a net $29.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GOTHAM ASSET MANAGEMENT LLC Bought 3.2 Million shares of PDL BioPharma Inc
TWO SIGMA INVESTMENTS LLC Bought 1.9 Million shares of PDL BioPharma Inc
BLACKROCK FUND ADVISORS Bought 1.2 Million shares of PDL BioPharma Inc